US EditionMenopause Hormone Therapy May Boost GLP-1 Drug Benefits
3 Articles
3 Articles
Menopause Hormone Therapy May Boost GLP-1 Drug Benefits
(MedPage Today) -- Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. Among 120 women with overweight or obesity...
What to consider about menopausal hormone replacement
Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against osteoporosis, heart disease, and possibly Alzheimer’s disease. It was thought that it generally preserved health and quality of life. That all changed in 2002 with the publication of the large “definitive” study, the Women’s Health Initiative (WHI), which cautioned that the risks of MHT outweighed the benefits. The unfavorabl…
A new study led by Mayo Clinic revealed that postmenopausal women who received menopausal hormone therapy lost 35% more weight while taking tirzepatide, a drug approved by the Food and Drug Administration for the treatment of overweight and obesity.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
